These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37453625)

  • 1. Dohongsamul-tang inhibits cardiac remodeling and fibrosis through calcineurin/NFAT and TGF-β/Smad2 signaling in cardiac hypertrophy.
    Hong MH; Jang YJ; Yoon JJ; Lee HS; Kim HY; Kang DG
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116844. PubMed ID: 37453625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
    Zhao M; Zhang J; Xu Y; Liu J; Ye J; Wang Z; Ye D; Feng Y; Xu S; Pan W; Wang M; Wan J
    Int Immunopharmacol; 2021 Oct; 99():108046. PubMed ID: 34435581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effects of myostatin inhibition on cardiac and skeletal muscles in a mouse model of pressure overload.
    Shi C; Zijlstra SN; de Wit S; Meijers WC; Aboumsallem JP; Silljé HHW; de Boer RA
    Am J Physiol Heart Circ Physiol; 2023 Jul; 325(1):H195-H201. PubMed ID: 37294894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
    Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
    Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
    Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
    Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
    Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-β/Smads and MAPKs signaling activated fibrosis.
    Chen H; Song H; Liu X; Tian J; Tang W; Cao T; Zhao P; Zhang C; Guo W; Xu M; Lu R
    Biomed Pharmacother; 2017 Nov; 95():461-468. PubMed ID: 28865366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linggui Zhugan Decoction () Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Mice by Suppressing TGF-β
    Wang L; Shi H; Huang JL; Xu S; Liu PP
    Chin J Integr Med; 2020 May; 26(5):345-352. PubMed ID: 30623345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
    You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
    Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
    Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
    Liu W; Zi M; Tsui H; Chowdhury SK; Zeef L; Meng QJ; Travis M; Prehar S; Berry A; Hanley NA; Neyses L; Xiao RP; Oceandy D; Ke Y; Solaro RJ; Cartwright EJ; Lei M; Wang X
    Circ Heart Fail; 2013 Jul; 6(4):833-44. PubMed ID: 23753531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
    Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
    Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload.
    Shi L; Zhu D; Wang S; Jiang A; Li F
    Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qindan Capsule Attenuates Myocardial Hypertrophy and Fibrosis in Pressure Overload-Induced Mice Involving mTOR and TGF-
    Bai W; Ren M; Cheng W; Lu X; Liu D; Wang B
    Evid Based Complement Alternat Med; 2021; 2021():5577875. PubMed ID: 34007292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
    Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
    Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.